LifeSci Capital Starts Catalyst Biosciences (CBIO) at Outperform

LifeSci Capital analyst Charles Zhu initiates coverage on Catalyst Biosciences (NASDAQ: CBIO) with a Outperform rating and a price target of $22.00.

For an analyst ratings summary and ratings history on Catalyst Biosciences click here. For more ratings news on Catalyst Biosciences click here.

Shares of Catalyst Biosciences closed at $13.27 yesterday.

You May Also Be Interested In

• Crescent Biopharma prices $125M public offering of shares and warrants
• Nomura/Instinet Reinstates Suruga Bank Ltd (8358:JP) (SRGBF) at Buy
• Crescent Biopharma launches public offering of shares and warrants